DE1290935B - Process for the preparation of 3, 20-dioxo-19-nor-delta 4, 9-pregnadiene - Google Patents
Process for the preparation of 3, 20-dioxo-19-nor-delta 4, 9-pregnadieneInfo
- Publication number
- DE1290935B DE1290935B DE1962R0032620 DER0032620A DE1290935B DE 1290935 B DE1290935 B DE 1290935B DE 1962R0032620 DE1962R0032620 DE 1962R0032620 DE R0032620 A DER0032620 A DE R0032620A DE 1290935 B DE1290935 B DE 1290935B
- Authority
- DE
- Germany
- Prior art keywords
- des
- known per
- methoxy
- dioxo
- manner known
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 238000000034 method Methods 0.000 title claims description 16
- 238000002360 preparation method Methods 0.000 title claims description 3
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 claims description 12
- RWRDLPDLKQPQOW-UHFFFAOYSA-N Pyrrolidine Chemical compound C1CCNC1 RWRDLPDLKQPQOW-UHFFFAOYSA-N 0.000 claims description 9
- QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 claims description 8
- YXFVVABEGXRONW-UHFFFAOYSA-N Toluene Chemical compound CC1=CC=CC=C1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 claims description 7
- 239000000203 mixture Substances 0.000 claims description 7
- NLKNQRATVPKPDG-UHFFFAOYSA-M potassium iodide Chemical compound [K+].[I-] NLKNQRATVPKPDG-UHFFFAOYSA-M 0.000 claims description 6
- 230000002378 acidificating effect Effects 0.000 claims description 5
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 claims description 4
- 239000007859 condensation product Substances 0.000 claims description 4
- 150000002081 enamines Chemical class 0.000 claims description 4
- 239000007800 oxidant agent Substances 0.000 claims description 4
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 claims description 3
- 239000003054 catalyst Substances 0.000 claims description 3
- 239000003795 chemical substances by application Substances 0.000 claims description 3
- 125000002534 ethynyl group Chemical group [H]C#C* 0.000 claims description 3
- 150000003335 secondary amines Chemical class 0.000 claims description 3
- 239000011734 sodium Substances 0.000 claims description 3
- 229910052708 sodium Inorganic materials 0.000 claims description 3
- 235000018185 Betula X alpestris Nutrition 0.000 claims description 2
- 235000018212 Betula X uliginosa Nutrition 0.000 claims description 2
- 239000002253 acid Substances 0.000 claims description 2
- 238000005903 acid hydrolysis reaction Methods 0.000 claims description 2
- 238000009833 condensation Methods 0.000 claims description 2
- 230000005494 condensation Effects 0.000 claims description 2
- 230000007062 hydrolysis Effects 0.000 claims description 2
- 238000006460 hydrolysis reaction Methods 0.000 claims description 2
- WLIADPFXSACYLS-RQOWECAXSA-N (z)-1,3-dichlorobut-2-ene Chemical compound C\C(Cl)=C\CCl WLIADPFXSACYLS-RQOWECAXSA-N 0.000 claims 2
- 235000018734 Sambucus australis Nutrition 0.000 claims 1
- 244000180577 Sambucus australis Species 0.000 claims 1
- 150000001735 carboxylic acids Chemical class 0.000 claims 1
- 150000002730 mercury Chemical class 0.000 claims 1
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 39
- YMWUJEATGCHHMB-UHFFFAOYSA-N dichloromethane Natural products ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 description 29
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 20
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N EtOH Substances CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 18
- UHOVQNZJYSORNB-UHFFFAOYSA-N Benzene Chemical compound C1=CC=CC=C1 UHOVQNZJYSORNB-UHFFFAOYSA-N 0.000 description 17
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 12
- 239000000047 product Substances 0.000 description 12
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 10
- 238000004458 analytical method Methods 0.000 description 7
- 150000001875 compounds Chemical class 0.000 description 7
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 6
- 239000000284 extract Substances 0.000 description 5
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 4
- ZAFNJMIOTHYJRJ-UHFFFAOYSA-N Diisopropyl ether Chemical compound CC(C)OC(C)C ZAFNJMIOTHYJRJ-UHFFFAOYSA-N 0.000 description 4
- JUJWROOIHBZHMG-UHFFFAOYSA-N Pyridine Chemical compound C1=CC=NC=C1 JUJWROOIHBZHMG-UHFFFAOYSA-N 0.000 description 4
- UIIMBOGNXHQVGW-UHFFFAOYSA-M Sodium bicarbonate Chemical compound [Na+].OC([O-])=O UIIMBOGNXHQVGW-UHFFFAOYSA-M 0.000 description 4
- 239000013078 crystal Substances 0.000 description 4
- 239000011541 reaction mixture Substances 0.000 description 4
- 238000003756 stirring Methods 0.000 description 4
- 238000002211 ultraviolet spectrum Methods 0.000 description 4
- ZWEHNKRNPOVVGH-UHFFFAOYSA-N 2-Butanone Chemical compound CCC(C)=O ZWEHNKRNPOVVGH-UHFFFAOYSA-N 0.000 description 3
- WFDIJRYMOXRFFG-UHFFFAOYSA-N Acetic anhydride Chemical compound CC(=O)OC(C)=O WFDIJRYMOXRFFG-UHFFFAOYSA-N 0.000 description 3
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 3
- ZMXDDKWLCZADIW-UHFFFAOYSA-N N,N-Dimethylformamide Chemical compound CN(C)C=O ZMXDDKWLCZADIW-UHFFFAOYSA-N 0.000 description 3
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 3
- 239000000741 silica gel Substances 0.000 description 3
- 229910002027 silica gel Inorganic materials 0.000 description 3
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 2
- 230000015572 biosynthetic process Effects 0.000 description 2
- IAQRGUVFOMOMEM-UHFFFAOYSA-N but-2-ene Chemical compound CC=CC IAQRGUVFOMOMEM-UHFFFAOYSA-N 0.000 description 2
- 238000006243 chemical reaction Methods 0.000 description 2
- 238000004587 chromatography analysis Methods 0.000 description 2
- 238000004090 dissolution Methods 0.000 description 2
- 239000000706 filtrate Substances 0.000 description 2
- HCWCAKKEBCNQJP-UHFFFAOYSA-N magnesium orthosilicate Chemical compound [Mg+2].[Mg+2].[O-][Si]([O-])([O-])[O-] HCWCAKKEBCNQJP-UHFFFAOYSA-N 0.000 description 2
- 239000000391 magnesium silicate Substances 0.000 description 2
- 229910052919 magnesium silicate Inorganic materials 0.000 description 2
- 235000019792 magnesium silicate Nutrition 0.000 description 2
- NUJOXMJBOLGQSY-UHFFFAOYSA-N manganese dioxide Chemical compound O=[Mn]=O NUJOXMJBOLGQSY-UHFFFAOYSA-N 0.000 description 2
- 229910052757 nitrogen Inorganic materials 0.000 description 2
- 239000011591 potassium Substances 0.000 description 2
- 229910052700 potassium Inorganic materials 0.000 description 2
- UMJSCPRVCHMLSP-UHFFFAOYSA-N pyridine Natural products COC1=CC=CN=C1 UMJSCPRVCHMLSP-UHFFFAOYSA-N 0.000 description 2
- 238000001953 recrystallisation Methods 0.000 description 2
- 229910000030 sodium bicarbonate Inorganic materials 0.000 description 2
- 235000017557 sodium bicarbonate Nutrition 0.000 description 2
- 238000005406 washing Methods 0.000 description 2
- CPUKWYXYHPOQJH-RDQPJNLGSA-N (8r,9s,10s,13s,14s)-17-ethenyl-10,13-dimethyl-2,3,4,5,6,7,8,9,11,12,14,15-dodecahydro-1h-cyclopenta[a]phenanthrene Chemical compound C1CCC[C@]2(C)[C@H]3CC[C@](C)(C(=CC4)C=C)[C@@H]4[C@@H]3CCC21 CPUKWYXYHPOQJH-RDQPJNLGSA-N 0.000 description 1
- YTKRILODNOEEPX-UHFFFAOYSA-N 1-chlorobut-2-ene Chemical compound CC=CCCl YTKRILODNOEEPX-UHFFFAOYSA-N 0.000 description 1
- VILCJCGEZXAXTO-UHFFFAOYSA-N 2,2,2-tetramine Chemical compound NCCNCCNCCN VILCJCGEZXAXTO-UHFFFAOYSA-N 0.000 description 1
- LSNNMFCWUKXFEE-UHFFFAOYSA-M Bisulfite Chemical compound OS([O-])=O LSNNMFCWUKXFEE-UHFFFAOYSA-M 0.000 description 1
- OJDDMHPRRUQPGU-UHFFFAOYSA-N CC(C)(CC)O.C1CCCCC1 Chemical compound CC(C)(CC)O.C1CCCCC1 OJDDMHPRRUQPGU-UHFFFAOYSA-N 0.000 description 1
- BVKZGUZCCUSVTD-UHFFFAOYSA-L Carbonate Chemical compound [O-]C([O-])=O BVKZGUZCCUSVTD-UHFFFAOYSA-L 0.000 description 1
- VEXZGXHMUGYJMC-UHFFFAOYSA-M Chloride anion Chemical compound [Cl-] VEXZGXHMUGYJMC-UHFFFAOYSA-M 0.000 description 1
- XDTMQSROBMDMFD-UHFFFAOYSA-N Cyclohexane Chemical compound C1CCCCC1 XDTMQSROBMDMFD-UHFFFAOYSA-N 0.000 description 1
- WRYNUJYAXVDTCB-UHFFFAOYSA-M acetyloxymercury Chemical compound CC(=O)O[Hg] WRYNUJYAXVDTCB-UHFFFAOYSA-M 0.000 description 1
- HSFWRNGVRCDJHI-UHFFFAOYSA-N alpha-acetylene Natural products C#C HSFWRNGVRCDJHI-UHFFFAOYSA-N 0.000 description 1
- ASGJEMPQQVNTGO-UHFFFAOYSA-N benzene chloroform Chemical compound C(Cl)(Cl)Cl.C1=CC=CC=C1.C1=CC=CC=C1 ASGJEMPQQVNTGO-UHFFFAOYSA-N 0.000 description 1
- 239000000378 calcium silicate Substances 0.000 description 1
- 229910052918 calcium silicate Inorganic materials 0.000 description 1
- OYACROKNLOSFPA-UHFFFAOYSA-N calcium;dioxido(oxo)silane Chemical compound [Ca+2].[O-][Si]([O-])=O OYACROKNLOSFPA-UHFFFAOYSA-N 0.000 description 1
- 229910052799 carbon Inorganic materials 0.000 description 1
- 125000004432 carbon atom Chemical group C* 0.000 description 1
- 150000001732 carboxylic acid derivatives Chemical class 0.000 description 1
- 239000003610 charcoal Substances 0.000 description 1
- XNMQEEKYCVKGBD-UHFFFAOYSA-N dimethylacetylene Natural products CC#CC XNMQEEKYCVKGBD-UHFFFAOYSA-N 0.000 description 1
- 239000012153 distilled water Substances 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 238000005837 enolization reaction Methods 0.000 description 1
- 230000032050 esterification Effects 0.000 description 1
- 238000005886 esterification reaction Methods 0.000 description 1
- 238000001704 evaporation Methods 0.000 description 1
- 230000008020 evaporation Effects 0.000 description 1
- 238000001914 filtration Methods 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- 230000036571 hydration Effects 0.000 description 1
- 238000006703 hydration reaction Methods 0.000 description 1
- XMBWDFGMSWQBCA-UHFFFAOYSA-N hydrogen iodide Chemical compound I XMBWDFGMSWQBCA-UHFFFAOYSA-N 0.000 description 1
- FUKUFMFMCZIRNT-UHFFFAOYSA-N hydron;methanol;chloride Chemical compound Cl.OC FUKUFMFMCZIRNT-UHFFFAOYSA-N 0.000 description 1
- 238000002329 infrared spectrum Methods 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 125000000325 methylidene group Chemical group [H]C([H])=* 0.000 description 1
- 229930014626 natural product Natural products 0.000 description 1
- 238000006386 neutralization reaction Methods 0.000 description 1
- 239000003960 organic solvent Substances 0.000 description 1
- 230000003647 oxidation Effects 0.000 description 1
- 238000007254 oxidation reaction Methods 0.000 description 1
- 239000002994 raw material Substances 0.000 description 1
- 238000010992 reflux Methods 0.000 description 1
- 238000007363 ring formation reaction Methods 0.000 description 1
- 150000003839 salts Chemical class 0.000 description 1
- CGRKYEALWSRNJS-UHFFFAOYSA-N sodium;2-methylbutan-2-olate Chemical compound [Na+].CCC(C)(C)[O-] CGRKYEALWSRNJS-UHFFFAOYSA-N 0.000 description 1
- 239000002904 solvent Substances 0.000 description 1
- -1 steroid compounds Chemical class 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 229920003002 synthetic resin Polymers 0.000 description 1
- 239000000057 synthetic resin Substances 0.000 description 1
- JOXIMZWYDAKGHI-UHFFFAOYSA-N toluene-4-sulfonic acid Chemical compound CC1=CC=C(S(O)(=O)=O)C=C1 JOXIMZWYDAKGHI-UHFFFAOYSA-N 0.000 description 1
- 238000006257 total synthesis reaction Methods 0.000 description 1
- 229960001124 trientine Drugs 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
- A61K31/567—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in position 17 alpha, e.g. mestranol, norethandrolone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/58—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C49/00—Ketones; Ketenes; Dimeric ketenes; Ketonic chelates
- C07C49/587—Unsaturated compounds containing a keto groups being part of a ring
- C07C49/613—Unsaturated compounds containing a keto groups being part of a ring polycyclic
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C49/00—Ketones; Ketenes; Dimeric ketenes; Ketonic chelates
- C07C49/587—Unsaturated compounds containing a keto groups being part of a ring
- C07C49/753—Unsaturated compounds containing a keto groups being part of a ring containing ether groups, groups, groups, or groups
- C07C49/755—Unsaturated compounds containing a keto groups being part of a ring containing ether groups, groups, groups, or groups a keto group being part of a condensed ring system with two or three rings, at least one ring being a six-membered aromatic ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C69/00—Esters of carboxylic acids; Esters of carbonic or haloformic acids
- C07C69/02—Esters of acyclic saturated monocarboxylic acids having the carboxyl group bound to an acyclic carbon atom or to hydrogen
- C07C69/22—Esters of acyclic saturated monocarboxylic acids having the carboxyl group bound to an acyclic carbon atom or to hydrogen having three or more carbon atoms in the acid moiety
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J41/00—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J5/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J61/00—Steroids in which the cyclopenta(a)hydrophenanthrene skeleton has been modified by contraction of only one ring by one or two atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J7/00—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J75/00—Processes for the preparation of steroids in general
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Steroid Compounds (AREA)
Description
Amerikanische Autoren haben kürzlich, die Her- das dem aus Tetrahedron Letters, 1961 (3), S. 128, Stellung von 19-Nor-<d4>9-3-keto-steroiden, einer neuen bekannten Verfahren entspricht. -Die Temperatur-Klasse von biologisch wirksamen Steroidverbindungen, bedingungen dieses Verfahrens sind jedoch nicht auf beschrieben (s. MeI Per elm a η und Mitarbeiter, 4,5-Seco-3,5,20-trioxo-19-nor-Zl0-pregnen anwendbar, J. Am. Chem. Soc, 82 [I960], 2402/2403). 5 da sich in dem erforderlichen alkalischen Milieu dieAmerican authors recently reported that the method from Tetrahedron Letters, 1961 (3), p. 128, position of 19-nor- <d 4> 9 -3-keto-steroids, corresponds to a new known method. -The temperature class of biologically active steroid compounds, the conditions of this process are not described on (see MeI Per elm a η and coworkers, 4,5-Seco-3,5,20-trioxo-19-nor-Zl 0 - Pregnen applicable, J. Am. Chem. Soc, 82 [1960], 2402/2403). 5 because in the required alkaline environment the
Unter den von den Autoren aufgezählten Verbin- Konfiguration am Kohlenstoffatom 17 unter gleichdungen befindet sich das 3,20-Dioxo-19-nor-Zl4i9-preg- zeitiger Enolisierung der 20-Ketogruppe umkehren nadien, jedoch konnte diese Verbindung nicht in kann, was in der Gonanreihe nicht problematisch ist. reinem Zustand isoliert werden. Wenn die Reaktion jedoch erfindungsgemäß bei einerAmong the connection configuration at carbon atom 17 listed by the authors is the 3,20-dioxo-19-nor-Zl 4i9 -preg-time enolization of the 20-keto group, but this connection could not do what is not problematic in the gonan series. can be isolated in their pure state. However, if the reaction according to the invention at a
Die vorliegende Erfindung betrifft ein neues Ver- io Temperatur um O0C durchgeführt wird, wird selektiv fahren zur Herstellung von 3,20-Dioxo-19-nor- 3,20-Dioxo-19-nor-zl4'9-pregnadien erhalten, das ab-The present invention relates to a new encryption io temperature at 0 ° C is carried out, 9 -Pregnadien is selectively drive for the preparation of 3,20-dioxo-19-nor-3,20-dioxo-19-nor-zl 4 'obtained that from-
J4'8-pregnadien. Die beim erfindungsgemäßen Ver- solut frei vom 17a-Ispmeren ist.J 4 ' 8 -pregnadien. Which is free from 17a-ismers in the case of the solute according to the invention.
fahren auftretenden Zwischenverbindungen sind neue Das folgende Beispiel, dessen drei letzte Stufen aufdrive interconnections occurring are new The following example whose last three stages are on
Substanzen. dem Reaktionsschema dargestellt sind, erläutert dasSubstances. the reaction scheme illustrates that
Das erfindungsgemäße Verfahren gestattet die Her- 15 Verfahren der Erfindung. Stellung von reinem 3,20-Dioxo-19-nor-ZI4> "-pregnadienThe method of the invention allows the methods of the invention to be produced. Position of pure 3,20-dioxo-19-nor-ZI 4> "-pregnadiene
durch Totalsynthese, !so daß man nicht mehr auf teure Beispielby total synthesis, so that one is no longer on expensive example
Naturprodukte als Ausgangsmaterialien angewiesen ist. Herstellung von 3,20-Dioxo-19-nor-zl *· »-pregnadien (I)Relies on natural products as raw materials. Production of 3,20-Dioxo-19-nor-zl * · »-pregnadiene (I)
Das erfindungsgemäße Verfahren besteht darin, Stufe A-OxydationThe process according to the invention consists in stage A - oxidation
daß man 5-Methoxy-17/?-hydroxy-,ds'7'9-des-A-östra- aothat one has 5-methoxy-17 /? - hydroxy-, d s ' 7 ' 9 -des-A-oestra- ao
trien mit einem alkalischen Oxydationsmittel in an Man löst 3 g 5-Methoxy-17|S-hydroxy-Zl5'7'9-des-trien with an alkaline oxidizing agent in one dissolve 3 g of 5-methoxy-17 | S-hydroxy-Zl 5 ' 7 ' 9 -des-
sich bekannter Weise oxydiert, das erhaltene 5-Me- A-östratrienvomF. = 69oC,[a]2 0 0 = +15D±3(c==l0/0, thoxy-17-oxo-^5'7'9-des-A-östratrien in alkalischem Methanol), hergestellt nach dem Verfahren von Milieu in an sich bekannter Weise in 17a-Stellung L. Veil uz und Mitarbeitern, Comptes rendus de äthinyliert, das erhaltene 5-Methoxy-17/S-hydroxy- 25 l'Acadomie des Sciences, 250, S. 1084 (1960), in 400 ecm 17a-äthinyl-Zl5'''9-des-A-östratien mit einem funk- Methylenchlorid, fügt 100 mg wasserfreies Kaliumtionellen Derivat einer Carbonsäure in an sich be- carbonat und 30 g Mangandioxyd zu und rührt die kannter Weise in 170-Steilung verestert, das erhaltene Reaktionsmischung 56 Stunden bei Raumtemperatur. Äthinylderivat in Gegenwart eines Queeksilbersalzes Man filtriert, dampft das Filtrat unter Vakuum zur in an sich bekannter Weise hydratisiert, das gebildete 30 Trockne ein und kristallisiert den Rückstand aus 5-Methoxy-17i3-acetoxy-17öc-acetyl-zls:7'9-des-A-östra- Äthanol. Man erhält das 5-Methoxy-17-oxo-<d5'7-9-des- -trien. in an sich bekannter Weise einer Reduktion nach - A-östratrien vom F. = 890C, [a]i°-=H-99° (c = 1 %» Birch und anschließender Hydrolyse mit Salzsäure Methanol).is oxidized in a known manner, the 5-Me-A-estatriene obtained from F. = O C, [a] 2 0 0 D = +15 ± 3 (c == l 0/0, thoxy-17-oxo ^ 5 '7' 9 -des-A-östratrien in alkaline methanol) 69, according to the method of Milieu in a manner known per se in 17a-position L. Veil uz and coworkers, Comptes rendus de äthinyliert, the resulting 5-methoxy-17 / S-hydroxy-25 l'Acadomie des Sciences, 250, p. 1084 (1960), in 400 ecm 17a-äthinyl-Zl 5 ''' 9 -des-A-oestratien with a funk- methylene chloride, adds 100 mg of anhydrous potassium tional derivative of a carboxylic acid in itself carbonate and 30 g of manganese dioxide and stirs esterified in the known manner in 170 degrees, the resulting reaction mixture for 56 hours at room temperature. Ethynyl derivative in the presence of a queeksilver salt. It is filtered, the filtrate is evaporated in vacuo to a known manner, the dryness formed is evaporated and the residue is crystallized from 5-methoxy-17i3-acetoxy-17o-acetyl-zl s : 7 ' 9 - des-A-estra-ethanol. To yield the 5-methoxy-17-oxo- <d 5 '7-9 -des- -triene. in a manner known per se, a reduction according to - A-estatrien of F. = 89 0 C, [a] i ° - = H-99 ° (c = 1% »Birch and subsequent hydrolysis with hydrochloric acid methanol).
unterwirft, das erhaltene 5-Oxo-20-hydroxy-zl9-l9-nör- Das Produkt ergibt sich in Form von weißen, stern-subjects, the obtained 5-oxo-20-hydroxy-zl 9 -l9-nör- The product results in the form of white, star-
des-A-pregnen mit Hilfe eines sauren Oxydationsmittels 35 förmigen Kristallen, die in Methyläthylketon und in an sich bekannter Weise in 20-Stellung oxydiert, Äthylacetat sehr löslich und in heißem Alkohol und das erhaltene 5,20-Dioxo-Zli)-19-nor-des-A-pregnen mit heißem Isopropyläther löslich sind, einem geringen Überschuß eines sekundären Amins - - ·des-A-pregnen with the help of an acidic oxidizing agent 35-shaped crystals which are oxidized in methyl ethyl ketone and in a manner known per se in the 20-position, ethyl acetate is very soluble and in hot alcohol and the 5,20-dioxo-Zl i) -19 obtained -nor-des-A-pregnen are soluble with hot isopropyl ether, a small excess of a secondary amine - - ·
bei einer Temperatur von —5 bis — 10°Cin Abwesen- Analyse: C15H18O2 = 230,30. heit eines sauren Katalysators selektiv in 5-Stellung 4° Berechnet .. .· C 78,23%, H 7,88%; umsetzt, das erhaltene Enamin mit 1,3-DichIor- gefunden ... C78,2%, H7,8%.at a temperature of -5 to -10 ° C. Absence analysis: C 15 H 18 O 2 = 230.30. an acidic catalyst selectively in the 5-position 4 ° Calculated .. · C 78.23%, H 7.88%; reacted, the enamine obtained was found with 1,3-dichloro- ... C78.2%, H7.8%.
2-buten in an sich bekannter Weise kondensiert, das „2-butene condensed in a manner known per se, the "
Kondensationsprodukt in an sich bekannter Weise UV-Spektrum in Äthanol: sauer hydrolysiert und das erhaltene 4,5-Seco-3,5,20- λτηαχ =279πιμ, }*m= 81,8; trioxo-19-nor-/d9-pregnen mit Hilfe eines alkalischen 45 ληαχ = 287,5 ηιμ., l?ra = 79,0. Mittels bei einer Temperatur um O0C selektiv zujdem : Condensation product in a manner known per se, UV spectrum in ethanol: acid hydrolyzed and the 4,5-seco-3,5,20- λτηαχ = 279πιμ,} * m = 81.8; trioxo-19-nor- / d 9 -pregnen with the help of an alkaline 45 ληαχ = 287.5 ηιμ., l? ra = 79.0. In addition, at a temperature around O 0 C selectively:
gewünschten 3,20-Dioxo-19-nor-Zl4'9-pregnadien eye- Die Verbindung wurde in der Literatur noch nichtdesired 3,20-Dioxo-19-nor-Zl 4 ' 9 -pregnadien eye- The compound has not yet been found in the literature
lisiert. beschrieben.lized. described.
Eine bevorzugte Ausfünrungsform des erfindungs- Stufe B ■ ÄthinylierungA preferred Ausfünrungsform of the invention stage B ■ ethynylation
gemäßen Verfahrens ist durch folgende Merkmale aus- 50according to the method is characterized by the following features
gezeichnet: Man gibt 30 ecm einer 0,99 n-Toluollösung vondrawn: 30 ecm of a 0.99 n-toluene solution are added
Natrium-tert.-amylat in 270 ecm wasserfreies Benzol,Sodium tert-amylate in 270 ecm anhydrous benzene,
a) Zur Bildung des 5-Monoenamins. wird Pyrrolidin bringt die Mischung unter Stickstoff auf - 6O0C unda) For the formation of 5-monoenamine. is pyrrolidine brings the mixture under nitrogen to -6O 0 C and
in geringem Überschuß, der unter 10% der iejtet 30 Minuten Acetylen durch. Man bringt auf theoretischen Menge liegt, angewandt; 55 Raumtemperatur, fügt unter Rühren 40 ecm einerin a slight excess, of less than 10% of the i e j tet 30 minutes acetylene. One brings to theoretical amount is applied; 55 room temperature, add 40 ecm one with stirring
b) die Kondensation des Enamins Il mit 1,3-Di- Benzollösung von 2,173 gin Methanol rechtsdrehendem chlor-2-buten wird in Gegenwart von Kalium- 5-Methoxy-17-oxo-Zl5'7-9-des-A-östratrien zu und läßt jodid vorgenommen; die Reaktionsmischung bei Raumtemperatur 2 Stundenb) the condensation of the enamine II with 1,3-di- benzene solution of 2.173 gin methanol dextrorotatory chloro-2-butene in the presence of potassium 5-methoxy-17-oxo-Zl 5 '7-9 -des-A estatria closed and iodide made; the reaction mixture at room temperature for 2 hours
N j. TT j ι j T^- j - j.· j 1 χ TTT stehen. Man gießt dann in Wasser, neutralisiert durch N y. TT j ι j T ^ - j - j. J 1 χ TTT stand. It is then poured into water, neutralized through
c) diesaureHydrolysedesKondensationsproduktsIII 6o z be VOQ Essi ä dekantiert, extrahiert die wird mit Hilfe einer Mischung von Schwefelsaure wä|ri phase J* j^ vereini dann die c) the acid hydrolysis of the condensation product III 6o z be VOQ Essi ä decanted, which is extracted with the help of a mixture of sulfuric acid wä | ri phase J * j ^ then combine the
und Essigsaure durchgeführt; ^^ phasen) trocknet ^ verdampft im Vaku^m and acetic acid carried out; ^^ phases) dries ^ evaporates in vacu ^ m
d) als alkalisches Cyclisierungsmittel wird Natrium- zur Trockne. Der Rückstand wird aus Cyclohexan tert.-amylat, gelöst in Toluol, verwendet. umkristallisiert und ergibt 5-Methoxy-17/3-hydroxy-d) as an alkaline cyclizing agent, sodium becomes dry. The residue is made from cyclohexane tert-amylate, dissolved in toluene, is used. recrystallizes and gives 5-methoxy-17/3-hydroxy-
65 17oc-äthinyl-Zls'7'I)-des-A-östratrien vom F. = 98,50C,65 17oc-äthinyl-Zl s ' 7 ' I) -des-A-estatrien from F. = 98.5 0 C,
In der deutschen Auslegeschrift 1201 345 wurde [oi]i° = —70,6° (c = 1%, Methanol), bereits ein Verfahren zur Cyclisierung eines 4,5-Sexo- Das Produkt ergibt sich in Form von weißenIn the German Auslegeschrift 1201 345 [oi] i ° = -70.6 ° (c = 1%, methanol), already a process for the cyclization of a 4,5-sexo The product results in the form of white
3,5-dioxo-gonens bei Raumtemperatur vorgeschlagen, Nadeln, die in Alkohol, Äther, Aceton, Benzol und3,5-dioxo-gonens suggested at room temperature, needles that are in alcohol, ether, acetone, and benzene
■Chloroform sehr löslich und in Wasser unlöslich sind.■ Chloroform very soluble and insoluble in water are.
Analyse: C17H20O2 = 256,33.
Berechnet ... C 78,66%, H 7,86%, O 12,48%;
gefunden ... C 79,8%, H 7,8%, O 12,4%.Analysis: C 17 H 20 O 2 = 256.33.
Calculated ... C 78.66%, H 7.86%, O 12.48%;
found ... C 79.8%, H 7.8%, O 12.4%.
Das IR-Spektrum zeigt insbesondere die Banden bei 3603 und 3310 cm"1.The IR spectrum shows in particular the bands at 3603 and 3310 cm " 1 .
Die Verbindung wurde in der Literatur noch nicht beschrieben.The compound has not yet been described in the literature.
Stufe C: VeresterungStage C: esterification
Stufe E: ReduktionLevel E: reduction
Man gibt unter Kühlen 0,786 g Lithium in kleinen Stücken in 369 ecm flüssiges Ammoniak, fügt 72 ecm wasserfreienÄther und 1,141 g 5-Methoxy-17/3-acetoxy-17«-acetyl-J5'7;9-des-A-östratrien, gelöst in 150 ecm wasserfreiem Äther, zu und hält die Reaktionsmischung unter Rühren in Stickstoffatmosphäre IVa Stunden bei -450C. Man fügt dann langsam ίο 70 ecm wasserfreies Methanol zu und dann bei —45° C im Verlauf einer Stunde 3,6 g Lithium. Man verdampft das Ammoniak, nimmt in einer Mischung von 300 ecm Wasser und 200 ecm Äther auf, wäscht mit Wasser, trocknet und verdampft im Vakuum zur Trockne.0.786 g of lithium are added in small pieces to 369 ecm of liquid ammonia with cooling, 72 ecm of anhydrous ether and 1.141 g of 5-methoxy-17/3-acetoxy-17 «-acetyl-I 5 ' 7 are added ; 9 -des-A-östratrien dissolved in 150 cc of anhydrous ether to and maintaining the reaction mixture under stirring in nitrogen atmosphere IVa hours at -45 0 C. is then added slowly ίο 70 cc of anhydrous methanol and then at -45 ° C in 3.6 g lithium over one hour. The ammonia is evaporated, taken up in a mixture of 300 ecm water and 200 ecm ether, washed with water, dried and evaporated to dryness in a vacuum.
Man löst 2,08 g 5-Methoxy-17^-hydroxy-17«-äthinyl-zl5i7'9-des-A-östratrien in 20 ecm Essigsäureanhydrid, fügt 1 g p-Toluolsulfonsäure zu, rührt bis zur 15 Der Rückstand wird in 50 ecm Methanol, 12,5 ecm Auflösung und läßt dann 24 Stunden bei Raum- Salzsäure und 25 ecm Wasser gelöst und 1 Stunde temperatur stehen. Man gießt in Wasser, rührt unter Rückfluß gekocht. Man gießt in Wasser, extra-V2 Stunde und extrahiert mit Methylenchlorid. Die hiert mit Methylenchlorid, verdampft im Vakuum zur Extrakte werden getrocknet und dann unter Vakuum Trockne und chromatographiert den Rückstand an zur Trockne eingedampft. Der Rückstand wird in 20 Silicagel. Eluieren mit Methylenchlorid, das 10% Methylenchlorid über Magnesiumsilikat entfärbt. Aceton enthält, ergibt amorphes 5-Oxo-20-hydroxy-2.08 g of 5-methoxy-17 ^ -hydroxy-17'-ethinyl-zl 5i7 ' 9 -des-A-estatriene are dissolved in 20 ecm of acetic anhydride, 1 g of p-toluenesulphonic acid is added, and the mixture is stirred until the residue becomes in 50 ecm methanol, 12.5 ecm dissolution and then allowed to dissolve in room hydrochloric acid and 25 ecm water for 24 hours and stand at temperature for 1 hour. It is poured into water, stirred and refluxed. It is poured into water for an extra V for 2 hours and extracted with methylene chloride. The hiert with methylene chloride, evaporated in vacuo to the extracts are dried and then dry in vacuo and chromatographed the residue evaporated to dryness. The residue is dissolved in silica gel. Elute with methylene chloride, which decolorizes 10% methylene chloride over magnesium silicate. Contains acetone, gives amorphous 5-oxo-20-hydroxy-
/l9-19-nor-des-A-pregnen, [κ]1° = -23,3° (c = 1,3%, Methanol)./ l 9 -19-nor-des-A-pregnen, [κ] 1 ° = -23.3 ° (c = 1.3%, methanol).
Das Produkt ist sehr löslich in Aceton, Benzol und Chloroform und wenig löslich in Äther.The product is very soluble in acetone, benzene and chloroform and not very soluble in ether.
UV-Spektrum in Äthanol:UV spectrum in ethanol:
= 240 πιμ, }*, = 557.= 240 πιμ,} *, = 557.
Durch Umkristallisieren aus Isopropyläther erhält man 5-Methoxy-17/3-acetoxy-17«-äthinyl-Zl5''-°-des-A-östratrien vom F. = 93,5°C, [«]?? = —54° (c = 1,5%, Methanol).Recrystallization from isopropyl ether gives 5-methoxy-17/3-acetoxy-17 "-äthinyl-Zl 5 " - ° -des-A-estatriene with a temperature of 93.5 ° C, [«] ?? = -54 ° (c = 1.5%, methanol).
Das Produkt ergibt sich in Form von weißen Kristallen, die in Alkohol löslich und in Wasser unlöslich sind.The product emerges in the form of white crystals that are soluble in alcohol and insoluble in water are.
Analyse: C19H22O3 = 298,37.
Berechnet ... C 76,48%, H 7,43%;
gefunden ... C76,5%, H7,4°/0.Analysis: C 19 H 22 O 3 = 298.37.
Calculated ... C 76.48%, H 7.43%;
found ... C76.5%, H7.4 ° / 0 .
Die Verbindung wurde in der Literatur noch nicht beschrieben.The compound has not yet been described in the literature.
Stufe D: Wasseranlagerung
a) Herstellung des KatalysatorsLevel D: water retention
a) Preparation of the catalyst
Die Verbindung wurde in der Literatur noch nicht beschrieben.The compound has not yet been described in the literature.
Stufe F: OxydationLevel F: Oxidation
Man löst 100 mg 5-Oxo-20-hydroxy-Zl0-19-nor-des-A-pregnen in 10 ecm Essigsäure, fügt 0,25 ecm einer Lösung von 600 mg Chromtrioxyd in 5 ecm Essigr· säure, die 10% Wasser enthält, zu, rührt die Reaktionsmischung bei Raumtemperatur 1 Stunde, fügt dann 0,5 ecm Methanol zu und läßt 45 Minuten stehen. Man gießt in Wasser, neutralisiert durch Zugabe von100 mg of 5-oxo-20-hydroxy-Zl 0 -19-nor-des-A-pregnen are dissolved in 10 ecm of acetic acid, 0.25 ecm of a solution of 600 mg of chromium trioxide in 5 ecm of acetic acid, which contains 10% Contains water, the reaction mixture is stirred at room temperature for 1 hour, then 0.5 ecm of methanol is added and the mixture is left to stand for 45 minutes. It is poured into water, neutralized by adding
Man gibt 200 g sauren Kunstharzaustauscher in
11 lnormale wäßrige Schwefelsäure, rührt 30 Minuten 40 Natriumbicarbonat und extrahiert mit Methylen-
und dekantiert. Man wäscht mit Wasser, fügt dann chlorid. Die Extrakte ergeben durch Eindampfen200 g of acidic synthetic resin exchanger are added
11 Normal aqueous sulfuric acid, stir 30 minutes 40 sodium bicarbonate and extract with methylene and decanted. Wash with water, then add chloride. The extracts are obtained by evaporation
unter Vakuum einen Rückstand von 5,20-Dioxo- Δ 9-19-nor-des-A-pregnen, das man durch Chromatographieren an Silicagel reinigt. Man erhält ein weißes Produkt vom F. = 8O0C, [oc]l° = +53° (c = 0,75%, Methanol), das sehr löslich in den üblichen organischena residue of 5,20-dioxo- Δ 9 -19-nor-des-A-pregnen under vacuum, which is purified by chromatography on silica gel. A white product with a mp = 8O 0 C, [oc] l ° = + 53 ° (c = 0.75%, methanol), which is very soluble in the usual organic
3 g Mercuri-acetat und 11 Wasser zu und rührt 10 Minuten. Man dekantiert und wäscht mit Wasser.3 g of mercury acetate and 11 water are added and the mixture is stirred 10 mins. It is decanted and washed with water.
b) Hydratisierungb) hydration
Man gibt 5 g S-Methoxy-U/J-acetoxy-^a-äthinyl-Zl5-7'9-des-A-östratrien und 62,5 g des wie oben beschrieben erhaltenen Katalysators in 125 ecm Äthanol und erhitzt unter Rühren 7 Stunden zum Rückfluß. Man filtriert, fügt zum Filtrat 600 ecm Methylenchlorid, entzieht den Alkohol durch mehrmaliges Waschen mit destilliertem Wasser, behandelt mit Tierkohle, filtriert und verdampft dann unter Vakuum zur Trockne. Der Rückstand wird aus Äthanol umkristallisiert und ergibt 5-Methoxy-17/S-acetoxy-17a-acetykds'7'9-des-A-östratrien vom F. = 13O0C, [*]» == + 40° (c = 1%, Methanol).Add 5 g of S-Methoxy-U / J-acetoxy ^ a-ethynyl-Zl 5-7 '9 -des-A-östratrien and 62.5 g of the catalyst obtained as described above in 125 cc of ethanol and heated with stirring 7 hours to reflux. It is filtered, 600 ecm of methylene chloride is added to the filtrate, the alcohol is removed by washing several times with distilled water, treated with animal charcoal, filtered and then evaporated to dryness under vacuum. The residue is recrystallized from ethanol to yield 5-methoxy-17 / S-acetoxy-17a-acetykd s '7' 9 -des-A-östratrien mp = 13O 0 C, [*] "== + 40 ° ( c = 1%, methanol).
Das Produkt ergibt sich in Form von weißen Kristallen, die in Aceton, Benzol und Chloroform sehr löslich, in Isopropyläther und heißem Alkohol löslich und in Wasser unlöslich sind.The product results in the form of white crystals that exist in acetone, benzene and chloroform are very soluble, soluble in isopropyl ether and hot alcohol, and insoluble in water.
Lösungsmitteln und unlöslich in Wasser ist.Solvents and is insoluble in water.
Analyse: C16H22O2 = 246,34.
Berechnet ... C78,00%, H9,00%;
gefunden ... C77,7%, H8,8%.Analysis: C 16 H 22 O 2 = 246.34.
Calculated ... C78.00%, H9.00%;
found ... C77.7%, H8.8%.
UV-Spektrum in Äthanol:UV spectrum in ethanol:
= 239 πιμ, ε = 16 200.= 239 πιμ, ε = 16,200.
6060
Analyse: C19H24O4 = 316,38.
Berechnet ... C 72,12%, H 7,65%;
gefunden ... C72,2%, H7,4%.Analysis: C 19 H 24 O 4 = 316.38.
Calculated ... C 72.12%, H 7.65%;
found ... C72.2%, H7.4%.
Die Verbindung wurde in der Literatur noch nicht beschrieben.The compound has not yet been described in the literature.
Die Verbindung wurde in der Literatur noch nicht beschrieben.The compound has not yet been described in the literature.
Stufe G: Bildung des Enamins IIStage G: Formation of the enamine II
Man gibt 2 g 5,20-Dioxo--d9-19-nor-des-A-pregnen in 0,74 ecm Pyrrolidin. Durch leichtes Erwärmen bewirkt man die Auflösung. Man kühlt ab und fügt 5 ecm wasserfreies Methanol zu und läßt dann die Reaktionsmischung bei —5 bis —100C 1 Stunde stellen. Man saugt das gebildete Produkt ab, wäscht mit Methanol, trocknet und erhält das 5-Pyrrolidyl-20-oxo-ZlB(10>9<11»-19-nor-des-A-pregnadien(II) vom F. = 1420C, [»yg = +251° (c == 0,5%, Pyridin).2 g of 5,20-dioxo-d 9 -19-nor-des-A-pregnen are added to 0.74 ecm of pyrrolidine. The dissolution is effected by gentle heating. The mixture is cooled and added 5 cc of anhydrous methanol and then leaving the reaction mixture at -5 to -10 0 C for 1 hour filters. The product formed is filtered off with suction, washed with methanol, dried, and 5-pyrrolidyl-20-oxo-Zl B ( 10 > 9 < 11 >> -19-nor-des-A-pregnadiene (II) of F. = 142) is obtained 0 C, [»yg = + 251 ° (c == 0.5%, pyridine).
Das Produkt ergibt sichin.Form von gelben Nadeln, die in Benzol löslich und in Alkohol wenig löslich sind.The product is in the form of yellow needles, which are soluble in benzene and sparingly soluble in alcohol.
Analyse; C2OH219ON = 299,44.Analysis; C 2 OH 219 ON = 299.44.
λ Berechnet7.. N 4,68%;
.gefunden ... N 4,7%.λ Calculated 7 .. N 4.68%;
. found ... N 4.7%.
Die Verbindung wurde in- der Literatur noch nicht •beschrieben.The compound has not yet been described in the literature.
Stufe H: ^^
. . 19-nor'J2'9-pregnadien(IlI)Level H: ^^
. . 19-nor'J 2 ' 9 -pregnadien (IlI)
1010
-■ Man bringt 5,16 g 5-Pyrrolidyl-20-oxo-19-nor- ^I«io),i)(ii),des.A-pregnadien(n) vom F. = 142°C, ,[«]*> == +251° (c = 0,5%, Pyridin) unter Stickstoff in 40 ecm Dimethylformamid und fügt dann 2,88 g ^Kaliumiodid und 3,08 g l,3-Dichlor-2-buten zu. Die Reaktionsmischung wird-bei 00C I1I2 Stunden geöriihrt und dann bei Ö°C über Nacht stehengelassen. Man gießt in Wasser und extrahiert mit Äther. Die •Extrakte werden mit einer wäßrigen l%igen Natrium-•bisulfitlösung und dann mit Wasser gewaschen. Nach Trocknen und Filtrieren verdampft man im Vakuum zur Trockne und erhält 5,850 g des Produkts, das man kai- Magnesiumsilikat chromatographiert. Eluieren mit Methylenchlorid-ergibt 5 g SrChlor^^-seco-S^O-dioxo-19-nor-Zl 2'9-pregnadien (III), - ■ is brought 5.16 g of 5-pyrrolidyl-20-oxo-19-nor-I ^ "io), i) (ii), des.A-pregnadiene (n), mp = 142 ° C, [ «] *> == + 251 ° (c = 0.5%, pyridine) under nitrogen in 40 ecm of dimethylformamide and then add 2.88 g of potassium iodide and 3.08 g of 3-dichloro-2-butene. The reaction mixture is-with geöriihrt 0 0 C I 1 I 2 hours and then allowed to stand at east ° C overnight. It is poured into water and extracted with ether. The • extracts are washed with an aqueous 1% sodium • bisulfite solution and then with water. After drying and filtering, the mixture is evaporated to dryness in vacuo and 5.850 g of product are obtained, which is chromatographed on calcium silicate. Eluting with methylene chloride gives 5 g of SrChlor ^^ - seco-S ^ O-dioxo-19-nor-Zl 2 ' 9 -pregnadiene (III),
Das Produkt ergibt sich in Form eines blaßgelben Öls, das man so, wie es ist, für die folgende Verf ahrensistufö verwendet. . '". .. ".,'.-- The product is in the form of a pale yellow oil which is used as it is for the following process stage. . '". ..".,' .--
Die Verbindung wurde in der Literatur noch nicht beschrieben. ,. ■·.. ..- ·The connection has not yet been made in the literature described. ,. ■ · .. ..- ·
4,5-SecQ-3,5,20-trioxo-19-nor-^9-pregnen (IV)4,5-SecQ-3,5,20-trioxo-19-nor- ^ 9 -pregnen (IV)
'-■ Man löst "5 g'- ■ One solves "5 g
^a.^pregnadien (III) in 5 ecm: Essigsäure, bringt diese Lösung tropfenweise. in 25 ecm auf —15°C .'abgekühlte Schwefelsäure ein, rührt bei Raumtemperatur Va Stunde und gießt dann in Wasser. Man fügt bis zur Neutralisation Natriumbicarbonat izu, extrahiert mit Methylenchlorid, wäscht die Extrakte mit Wasser, trocknet, filtriert und verdampft im Vakuum .zur Trockne.. Der Rückstand wird an Silicagel chromatographiert und mit Methylenchlorid, ;das 4% Aceton enthält, eluiert. Man erhält 4,2 g 45-Seco-3,5,20-trioxo-19rnor-Zl9-pregnen(IV). __ . Das. Produkt ergibt sich in Form eines Öls, [«]» = +37° (C= 1%, Methanol).^ a. ^ pregnadiene (III) in 5 ecm: acetic acid, bring this solution drop by drop. in sulfuric acid cooled to -15 ° C. in 25 ecm, stirred at room temperature for about an hour and then poured into water. Sodium bicarbonate is added until neutralization, extracted with methylene chloride, the extracts washed with water, dried, filtered and evaporated in vacuo .to dryness .. The residue is chromatographed on silica gel and eluted with methylene chloride, which contains 4% acetone. 4.2 g of 45-seco-3,5,20-trioxo-19rnor-Zl 9 -pregnen (IV) are obtained. __. That. The product is in the form of an oil, [«]» = + 37 ° (C = 1%, methanol).
Die Verbindung wurde in der Literatur noch nicht beschrieben.The compound has not yet been described in the literature.
Stufe K: 3,20-Dioxo-19-nor-zl4'9-pregnadien(I)Level K: 3,20-Dioxo-19-nor-zl 4 ' 9 -pregnadiene (I)
Man löst 1,67 g 4,5-Seco-3,5,20-trioxo-19-nor- <d9-pregnen (IV) in 70 ecm wasserfreiem Toluol, kühlt ,auf 0° C ab amd.f ügt dann 4,2 ecm einer 1,28 η-Toluol- S5 lösung von Natrium-tert.-amylat zu.1.67 g of 4,5-seco-3,5,20-trioxo-19-nor- <d 9 -pregnen (IV) are dissolved in 70 ecm of anhydrous toluene, cooled, to 0 ° C. amd.f then 4.2 ecm of a 1.28 η-toluene-S5 solution of sodium tert-amylate.
Die Reaktionsmischung wird bei 0°C unter Stickstoff 2 Stunden und 20 Minuten gerührt. Dann versetzt man sie mit 0,4 ecm Essigsäure, wäscht^ mit,_ .'Wasser, trocknet und" verdampft im Vakuum zur M' Trockne. Der Rückstand kristallisiert leicht nach Waschen mit Äther und Stehenlassen im Eisbad. .Man reinigt durch Chromatographieren an Magne-,siumsilikat, Eluieren mit Methylenehlorid und nachfolgendes Umkristallisieren aus Methanol mit 50% Wasser.The reaction mixture is stirred at 0 ° C. under nitrogen for 2 hours and 20 minutes. Then added to 0.4 cc of acetic acid, washed with ^, _ .'Wasser, dried and "evaporated in vacuo to M 'dryness. The residue crystallizes easily, after washing with ether and left to stand in an ice bath. .MAN purified by chromatography on Magnesium silicate, eluting with methylene chloride and subsequent recrystallization from methanol with 50% water.
Ausbeute: 1 g (etwa 60% der.Theorie) an 3,20-Diketo-19-nor-J4'9-pregnadien (I) vom F. = 1040C, [φ0 = -209° (c = 0,5 %, Methanol).Yield: 1 g (about 60% der.Theorie) of 3,20-diketo-19-nor-J 4 '9 -Pregnadien (I), mp = 104 0 C, [φ 0 = -209 ° (c = 0.5%, methanol).
Das Produkt ergibt sich in Form von weißen Kristallen, die in den üblichen organischen Lösungsmitteln, wie Alkohol, Äther, Aceton, Benzol und Chloroform, sehr löslich, in Cyclohexan und Isopropyläther wenig löslich und in Wasser unlöslich sind.The product arises in the form of white Crystals that are found in common organic solvents, such as alcohol, ether, acetone, and benzene Chloroform, very soluble, sparingly soluble in cyclohexane and isopropyl ether and insoluble in water.
Analyse: C20H28O2 = 298,4.Analysis: C 20 H 28 O 2 = 298.4.
Berechnet ... C 80,49%, H 8,78%; gefunden ... C 80,4%, H 8,8%.Calculated ... C 80.49%, H 8.78%; found ... C 80.4%, H 8.8%.
UV-Spektrum:UV spectrum:
λτηίΐεχίοη 236 ΐημ, \fn — 163; λτηίΐεχίοη 236 ΐημ, \ f n - 163;
Hwn 303 ηιμ, \fm = 70O5 ε = 20 900. Hwn 303 ηιμ, \ f m = 70O 5 ε = 20,900.
Claims (5)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FR861132A FR1368728A (en) | 1961-05-08 | 1961-05-08 | Progesterone derivatives and method of preparation |
| FR866331A FR1370566A (en) | 1961-06-28 | 1961-06-28 | New process for the preparation of a 19-norprogesterone derivative and intermediates used in this process |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DE1290935B true DE1290935B (en) | 1969-03-20 |
Family
ID=26190434
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DE1962R0032620 Pending DE1290935B (en) | 1961-05-08 | 1962-05-03 | Process for the preparation of 3, 20-dioxo-19-nor-delta 4, 9-pregnadiene |
Country Status (3)
| Country | Link |
|---|---|
| CH (1) | CH411865A (en) |
| DE (1) | DE1290935B (en) |
| GB (3) | GB1001195A (en) |
-
1962
- 1962-04-27 CH CH510762A patent/CH411865A/en unknown
- 1962-05-03 DE DE1962R0032620 patent/DE1290935B/en active Pending
- 1962-05-08 GB GB1493764A patent/GB1001195A/en not_active Expired
- 1962-05-08 GB GB1493964A patent/GB1001197A/en not_active Expired
- 1962-05-08 GB GB1768862A patent/GB1001192A/en not_active Expired
Non-Patent Citations (1)
| Title |
|---|
| None * |
Also Published As
| Publication number | Publication date |
|---|---|
| GB1001197A (en) | 1965-08-11 |
| CH411865A (en) | 1966-04-30 |
| GB1001195A (en) | 1965-08-11 |
| GB1001192A (en) | 1965-08-11 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE1290935B (en) | Process for the preparation of 3, 20-dioxo-19-nor-delta 4, 9-pregnadiene | |
| DE1947221A1 (en) | 3-Aza-19-hydroxy-3,19-cyclo-A-homosteroids and a process for their preparation | |
| DE1668818A1 (en) | Steroid compound and process for its preparation | |
| DE1668205C3 (en) | 16 alpha-alkylthio-9beta, lOalpha steroids, processes for their preparation and pharmaceutical preparations containing them | |
| AT261130B (en) | Process for the production of the new 3.2 Dioxo 17α methyl 19 nor pregna 4,9,11 triens | |
| DE825686C (en) | Process for the conversion of í¸-20-cyanpregnenes with one or more nucleus-bound hydroxyl groups into 17 alpha-oxy-20-ketopregnanes | |
| DE1468880C (en) | Process for the preparation of 17,20-dehydro-steroids | |
| AT242873B (en) | Process for the preparation of testosterone-17-chloral-hemiacetal esters | |
| AT233184B (en) | Process for the preparation of 3-oxo-Δ <1,4> steroids | |
| AT271754B (en) | Process for the manufacture of new desA steroids | |
| AT239455B (en) | Process for the preparation of new 17α-acyloxy-6-methyl-16-methylenpregna-4,6-diene-3,20-diones | |
| AT209007B (en) | Process for the preparation of 9 α-halo-4-pregnen-16 α, 17 α, 21-triol-3, 11, 20-triones and their esters | |
| AT241705B (en) | Process for the production of new, unsaturated halogen steroids | |
| DE1643012B2 (en) | PROCESS FOR THE MANUFACTURING OF BUTENOLIDES | |
| DE2341062A1 (en) | NEW CYCLOHEXANE PENTOL DERIVATIVE AND METHOD FOR PRODUCING IT | |
| DE1618810C3 (en) | Process for the preparation of 3-oxo-gona-4,9,11 -trienes | |
| DE1468911C (en) | 3 alpha-hydroxy-11-oxo-5 beta, 16androsten and its esters and process for their preparation | |
| AT275059B (en) | Process for the production of new 17α-cyanoethinyl steroids | |
| CH575438A5 (en) | Cardiotropic (14-beta-18(epoxy-ethano-imino) - steroids | |
| DE1126384B (en) | Process for the preparation of 17 ª ‡ -low-alkyl and 17ª ‡ -low-alkynyl derivatives of 19-nor-í¸-androstene-3ª ‰, 17ª ‰ -diol | |
| DE1170948B (en) | Process for the preparation of 6ª ‡, 16ª ‡ -dimethyl-11ª ‰, 17ª ‡, 21-trihydroxy-4-pregnen-3, 20-dione or. its 21-acetate | |
| CH331692A (en) | Method of making steroids | |
| Bladon et al. | 954. Studies in the steroid group. Part LVII. Side-chain degradation of 3β-acetoxy-5α: 8α-epidioxyergosta-9: 22-diene | |
| DE1593524A1 (en) | Process for the preparation of 1,2alpha-methylene-19-nor-steroids | |
| DE2027539A1 (en) | New Cyclopentanphenanthren Verbin fertilize the androstane series and process for their production |